A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study. - Bafaloukos, Dimitrios; Linardou, Helena; Aravantinos, Gerasimos; Papadimitriou, Christos; Bamias, Aristotelis; Fountzilas, George; Kalofonos, Haralabos P.; Kosmidis, Paris; Timotheadou, Eleni; Makatsoris, Thomas; Samantas, Epaminondas; Briasoulis, Evangelos; et al. (BMC Medicine, 2010)